CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR ...
Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...
“This is cryoablation of breast cancer,” Dr. Katelin Holmes, a breast and surgical oncologist at Thomas Hospital, said.
The results of a new study just came in.
Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more ...
A Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic cancer by ...
February’s Cancer Prevention Month highlights Natchez’s cancer care resources, Mary Bird Perkins’ impact, and how lifestyle ...
SBIR funding helps medical startups move from research to commercialization. With the program stalled, the pipeline for ...
The last time you met with your doctor, they may have asked for permission to have an ambient listening tool tune in to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results